Announcement on Attending the Q3 2026 Collective Performance Briefing of Listed Companies in Shanghai Jurisdiction
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(688336)"Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd."Announcement on Attending the Q3 2026 Collective Performance Briefing of Listed Companies in Shanghai Jurisdiction
Filed with SSE · Stock code 688336 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. on 6ix
Story so far
- Announcement on Resolutions of the 19th Meeting of the 5th Board of Directors
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on the Listing and Trading of the Shares Vested during the First Vesting Period of the Initial Grant under the 2024 Restricted Stock Incentive Plan
Earlier from Sunshine Guojian Pharmaceutical (Shanghai)
- Announcement on Resolutions of the 19th Meeting of the 5th Board of Directors
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Sunshine Guojian Releases 2026 Interim Report:
- Announcement on the Listing and Trading of the Shares Vested during the First Vesting Period of the Initial Grant under the 2024 Restricted Stock Incentive Plan
- Announcement on Abnormal Fluctuations in Stock Trading
Follow Sunshine Guojian Pharmaceutical (Shanghai) into a list and get an email when it puts out news.
Follow Sunshine Guojian Pharmaceutical (Shanghai)